24422711000001105: Siltuximab (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

79144101000001114 Siltuximab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

79144201000001119 Siltuximab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Siltuximab	Is a	Monoclonal antibody agent	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Siltuximab 100mg powder for solution for infusion vials	Has specific active ingredient	False	Siltuximab	Inferred relationship	Existential restriction modifier
Siltuximab 400mg powder for solution for infusion vials	Has specific active ingredient	False	Siltuximab	Inferred relationship	Existential restriction modifier
Sylvant 400mg powder for concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd)	Has specific active ingredient	False	Siltuximab	Inferred relationship	Existential restriction modifier
Sylvant 100mg powder for concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd)	Has specific active ingredient	False	Siltuximab	Inferred relationship	Existential restriction modifier
Siltuximab 100mg powder for solution for infusion vials 1 vial	Has specific active ingredient	False	Siltuximab	Inferred relationship	Existential restriction modifier
Siltuximab 400mg powder for solution for infusion vials 1 vial	Has specific active ingredient	False	Siltuximab	Inferred relationship	Existential restriction modifier
Sylvant 400mg powder for concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd) 1 vial	Has specific active ingredient	False	Siltuximab	Inferred relationship	Existential restriction modifier
Sylvant 100mg powder for concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd) 1 vial	Has specific active ingredient	False	Siltuximab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets